Aggrastat Solution For Injection 50Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Aggrastat: Solution for injection (50mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TIROFIBAN blocks platelets from forming blood clots. It is used to prevent complications during episodes of chest pain or a heart attack, or during a procedure to treat a blocked artery of the heart.

In-Depth Information
Select a Medication

Aggrastat 50mcg/ml Premixed Solution for Injection

NDC: 000063739
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Unstable Angina, Acute Myocardial Infarction, NSTEMI

Sometimes used for but not FDA approved for the following conditions:
Coronary Artery Disease, Acute Myocardial Infarction, STEMI

Aggrastat 50mcg/ml Premixed Solution for Injection

Reported Side Effects for Aggrastat 50mcg/ml Premixed Solution for Injection

Intestinal Bleeding Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding In The Brain Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding In The Abdomen Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
2.0%*
Severity: MODERATE
Onset: RAPID
Excessive Sweating Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Slow Heart Beat Incidence:
4.0%*
Severity: SEVERE
Onset: RAPID
Pelvic Pain Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Aggrastat

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5